首页> 外文期刊>Vaccine >Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep
【24h】

Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep

机译:在核心和O-多糖合成和输出方面存在缺陷的粗糙突变体在间接ELISA中与平滑脂多糖反应产生抗体反应,对绵羊布鲁氏菌感染的效果不如Rev 1疫苗

获取原文
获取原文并翻译 | 示例
           

摘要

Classical brucellosis vaccines induce antibodies to the O-polysaccharide section of the lipopolysaccharide that interfere in serodiagnosis. Brucella rough (R) mutants lack the O-polysaccharide but their usefulness as vaccines is controversial. Here, Brucella melitensis R mutants in all main lipopolysaccharide biosynthetic pathways were evaluated in sheep in comparison with the reference B. melitensis Rev 1 vaccine. In a first experiment, these mutants were tested for ability to induce anti-O-polysaccharide antibodies, persistence and spread through target organs, and innocuousness. Using the data obtained and those of genetic studies, three candidates were selected and tested for efficacy as vaccines against a challenge infecting 100% of unvaccinated ewes. Protection by R vaccines was 54% or less whereas Rev 1 afforded 100% protection. One-third of R mutant vaccinated ewes became positive in an enzyme-linked immunosorbent assay with smooth lipopolysaccharide due to the core epitopes remaining in the mutated lipopolysaccharide. We conclude that R vaccines interfere in lipopolysaccharide immunosorbent assays and are less effective than Rev 1 against B. melitensis infection of sheep.
机译:古典布鲁氏菌病疫苗会诱导针对脂多糖O-多糖部分的抗体,这些抗体会干扰血清诊断。布鲁氏菌粗突变体缺乏O-多糖,但其作为疫苗的用途尚存争议。在这里,与参考B. melitensis Rev 1疫苗相比,在绵羊中评估了所有主要脂多糖生物合成途径中的布鲁氏菌R突变体。在第一个实验中,测试了这些突变体诱导抗O-多糖抗体的能力,在靶器官中的持久性和扩散性以及无害性。使用获得的数据和遗传研究的数据,选择了三个候选对象,并测试了其作为抗击感染100%未接种母羊的挑战的疫苗的功效。 R疫苗的保护率为54%或更少,而Rev 1提供100%的保护。由于核心表位保留在突变的脂多糖中,三分之一的R突变疫苗接种母羊在酶联免疫吸附试验中用光滑的脂多糖变为阳性。我们得出的结论是,R疫苗干扰脂多糖免疫吸附测定,对绵羊的B. melitensis感染的疗效不如Rev 1。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号